Identification of MMP9 as a novel key gene in mantle cell lymphoma based on bioinformatic analysis and design of cyclic peptides as MMP9 inhibitors based on molecular docking

Mantle cell lymphoma (MCL) is an aggressive disease. MCL is associated with poor patient prognosis and limited survival. To identify key genes and explore targeting cyclic peptide inhibitors for the treatment of MCL, we downloaded two gene expression profiles (GSE32018 and GSE9327) from the Gene Exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Wei, Li, Shawn Xiang, Wei, Minjie, Gao, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151885/
https://www.ncbi.nlm.nih.gov/pubmed/30226602
http://dx.doi.org/10.3892/or.2018.6682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151885/
https://www.ncbi.nlm.nih.gov/pubmed/30226602
http://dx.doi.org/10.3892/or.2018.6682

Ejemplares similares